Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 12/12/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Jeffrey Lazar?

Jeffrey D. Lazar

President

Lazar & Associates

HQ Phone:  (310) 453-3302

Direct Phone: (512) ***-****direct phone

Email: j***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Lazar & Associates

1516 S. Bundy Dr. 311

Los Angeles, California,90025

United States

Company Description

Lazar & Associates was founded to promote multi-cultural understanding through clear communication. We are in business to help companies and public agencies of all stripes participate fully in our ever changing global community. As the world gets smaller, Laza...more

Web References(14 Total References)


www.symbiosisaustin.org

Jeffrey D. Lazar, MD, Ph.D., President and Managing Director, Lazar Associates, LLC


www.symbiosisaustin.org

Jeffrey D. Lazar, MD, Ph.D., President and Managing Director, Lazar Associates, LLC
Jeffrey Lazar offers almost 40 years of clinical research experience across nearly all aspects of medicine and pharmacology. Jeff has had several successful careers -- as a bench scientist (he described the first renin inhibitor), a clinical scientist (he was the first to postulate a kinetic effect of estrogens on the renin reaction as a mechanism for the hypertension associated with oral contraceptives), a university professor (he was tenured at the Uniformed Services University - the Department of Defense Medical School), in the pharmaceutical industry (he was the founding director of the Early Clinical Research Group at Pfizer Central Research), and in the CRO industry (he was a senior executive at Pharmaco in Austin, TX, responsible for Toxicology, Phase I, Regulatory Affairs, and Worldwide Consulting Services). This has provided Jeff with a unique blend of hands-on experience across all aspects of drug, biologics, and device research. While at Pfizer, he was the manager responsible for the amlodipine (Norvasc®) NDA and was a senior member of the teams that developed fluconazole (Diflucan®), sertraline (Zoloft®), doxazosin (Cardura®), and azithromycin (Zithromax®/Z-Pac®). He has been involved with multiple NDAs across nearly all therapeutic areas. Jeff received his MD from the University of Michigan in Ann Arbor and his PhD from The University of Heidelberg (Germany). He trained in Internal Medicine at the University of Michigan Medical Center, and in Clinical Pharmacology at Vanderbilt University. He has over 40 peer-reviewed publications in the


www.summitpk.com [cached]

Jeffery D. Lazar, MD, PhD, Lazar Associates LLC
PK Solutions Pharmacokinetics Analysis


www.symbiosisaustin.org

Jeffrey D. Lazar, MD, Ph.D., President and Managing Director, Lazar Associates, LLC
Jeffrey Lazar offers almost 40 years of clinical research experience across nearly all aspects of medicine and pharmacology. Jeff has had several successful careers -- as a bench scientist (he described the first renin inhibitor), a clinical scientist (he was the first to postulate a kinetic effect of estrogens on the renin reaction as a mechanism for the hypertension associated with oral contraceptives), a university professor (he was tenured at the Uniformed Services University - the Department of Defense Medical School), in the pharmaceutical industry (he was the founding director of the Early Clinical Research Group at Pfizer Central Research), and in the CRO industry (he was a senior executive at Pharmaco in Austin, TX, responsible for Toxicology, Phase I, Regulatory Affairs, and Worldwide Consulting Services). This has provided Jeff with a unique blend of hands-on experience across all aspects of drug, biologics, and device research. While at Pfizer, he was the manager responsible for the amlodipine (Norvasc®) NDA and was a senior member of the teams that developed fluconazole (Diflucan®), sertraline (Zoloft®), doxazosin (Cardura®), and azithromycin (Zithromax®/Z-Pac®). He has been involved with multiple NDAs across nearly all therapeutic areas. Jeff received his MD from the University of Michigan in Ann Arbor and his PhD from The University of Heidelberg (Germany). He trained in Internal Medicine at the University of Michigan Medical Center, and in Clinical Pharmacology at Vanderbilt University. He has over 40 peer-reviewed publications in the


www.symbiosisaustin.org

Jeffrey D. Lazar, MD, Ph.D., President and Managing Director, Lazar Associates, LLC


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory